Skip to main content
OpenTrials
Completed

NCT Number: NCT00476203

Yoga Study in Breast Cancer Patients

This purpose of this study is to test whether a 6-month yoga program improves quality of life and reduces fatigue and weight gain in breast cancer survivors.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year–75 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Fred Hutchinson Cancer Research Center

Seattle, Washington, 98109, United States

About this study

Women who are overweight or obese have a higher risk of breast cancer than normal weight women. Furthermore, women who are overweight or obese or gain weight after diagnosis have an increased risk of recurrence or dying from breast cancer compared with normal weight women. Yoga has been associated with reduced weight gain and weight loss in persons without cancer. However, no studies have tested whether yoga leads to less weight gain or weight loss in breast cancer patients. Both obesity and the sequelae of breast cancer therapy can result in reduced health-related quality of life and severe fatigue, which may also be favorably affected by yoga practice. The specific aims of the proposed trial are to examine, in women with Stage 0-IIIa breast cancer who are at least 3 months post primary treatment for their disease (other than tamoxifen or aromatase inhibitors), the effects of a 6-month yoga intervention on health-related quality of life, fatigue, and body weight.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female
  • Age 21-75
  • Diagnosed with a primary breast cancer Stage 0-IIIa
  • Current tamoxifen or aromatase inhibitor use is allowed
  • At least 3 months post treatment (e.g., surgery, chemotherapy, or radiation therapy)
  • BMI: 24 kg/m2 or greater (If Asian or Asian-American BMI: 23 kg/m2 or greater)
  • No contraindications to participating in a yoga program
  • Able to come for clinic visits, and attend weekly classes, and fill out questionnaires and logs in English
  • Gives informed consent, agrees to be randomly assigned

Exclusion criteria

  • Plans to leave the study area within the follow-up period
  • Is pregnant or plans to become pregnant during the study period.
  • History of myocardial infarction (heart attack) or stroke in the previous 6 months, or diabetes (current diagnosis)
  • Has practiced yoga more than 1 time per month in the past six months.
  • Current use of medications likely to interfere with adherence to interventions or study outcomes
  • Alcohol or drug abuse, significant mental illness (as assessed by study staff impression)

Treatment and study plan

Yoga

Behavioral

Instructor-led yoga classes 1/time per week + 4 days of home practice

Delayed yoga classes

Other

Delayed yoga classes (after 6 months) offered [wait list control group]

Primary outcomes

  1. quality of life, fatigue, and body weight

    Time frame: baseline, 6 months, 12 months

Secondary outcomes

  1. waist and hip circumference

    Time frame: baseline, 6 months, 12 months

Sponsors and collaborators

Lead sponsor

Fred Hutchinson Cancer Center

Other

Collaborators

  • National Institutes of Health (NIH)

Registry information

Official study title

Effect of Yoga on Weight and Fatigue in Breast Cancer Patients Study

Acronym: Yoga

Important dates

Study start
2007
Primary completion
2010
Study completion
2011
First posted
May 21, 2007
Registry last updated
Nov 28, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.